Darryl D. Button
Analyst · Morgan Stanley
Thank you, Alex. Here on Slide 8, I would like to take a closer look at underlying earnings, which I'm pleased to say rose by 5%. In the Americas, higher earnings driven by our pensions and variable annuities were partly offset by higher sales-related expenses following strong sales growth. Underlying earnings in the Netherlands were stable at EUR 74 million. Non-life earnings, however, were disappointing as improved earnings from disability were offset by higher claims in general insurance. In the U.K., underlying earnings increased 4% as favorable equity markets, improved mortality and favorable claims experience were partly offset by continued impact of adverse persistency. Underlying earnings from New Markets were down at EUR 52 million. Earnings from asset management were up, despite the sale of Prisma last year, but were more than offset by lower underlying earnings as a result of our divestments in Spain, unfavorable claim experience in Central and Eastern Europe. Total holding cost decreased to EUR 35 million, mainly the result of lower interest expenses following debt redemptions and reduced operating expenses. Here on Slide 9, you can see that in the second quarter, net income was negatively impacted by fair value items, which I will address further on the next slide. Impairments were up modestly compared to last year and were largely related to structured assets in the Americas, our corporate bond and the U.K. and residential mortgage loans in the Netherlands. Other income amounted to EUR 27 million as the gain on the sale of the joint venture with Unnim was offset by charges in the U.K. related to business transformation costs, a loss on the divestment of Positive Solutions and a provision in the Netherlands following the KoersPlan verdict. The results of run-off businesses increased to EUR 13 million, mainly due to improved results in the life reinsurance business in the Americas. Slide 10 provides more detail on our fair value items, which totaled a loss of EUR 270 million. These fair value items can be broken down into 4 categories. The first category is investments which are carried at fair value. Long term, we expect this item to be 0. And in the current quarter, we did see underperformance coming from all asset classes in both the U.S. and the Netherlands. Next, we have our fair value hedging programs, where we largely have an accounting match, with the one notable exception being the required use of our own credit spread in the valuation of the liabilities. We also expect this category to average 0 over the long term, but of course, some period-to-period volatility will still occur. The third category is the fair value hedging where there's not an accounting match. We have discussed extensively the largest of these programs, the U.S. GMIB delta macro hedge and the more recently added equity collar hedge. In addition to these hedges, we also have a hedge program covering the debt benefits of our GMWB product that is included in this category due to its accounting treatment. In addition, we have other extreme event hedges, including protection against rapidly rising interest rates that provided some offset to the loss during the period. Furthermore, at the holding, there was an impact of EUR 32 million related to interest rate swaps backing our hybrid capital securities. The fourth category contains various items such as Medium Term Notes at the holding which are impacted by credit spread movements, foreign currency exchange movements and the impact of rising interest rates on the longevity swap. We continue to focus on cost efficiency. As shown on Slide 11, our operating expenses have increased this year compared to the first half of 2012. The primary reason for this increase is twofold: higher sales-related expenses as our U.S. business is rapidly growing and business transformation costs in the U.K. Excluding the transformation costs, our operating expenses rose 3%. In the Netherlands, expenses were lower due to the successful implementation of cost reductions. And in our New Markets, expenses are mainly higher due to the Hungarian insurance tax and the first-time inclusion of our new business in the Ukraine. Reducing costs and pursuing operational efficiencies continue to be a key priority for the company and an integral part of how we manage our day-to-day business. I'm pleased with the level of operational free cash flows as shown here on Slide 12. Operational free cash flows for the quarter totaled EUR 674 million, including EUR 308 million of positive market impact on onetime items, of which the majority was driven by the sharp increase in interest rates. Turning now to Aegon's capital position at the end of the second quarter here on Slide 13. Our group IGD ratio decreased slightly to 220%, due mostly to the impact of the final 2012 dividend paid in June and the cash used for the preferred share transaction. As I highlighted during our recent Analyst & Investor Conference a few weeks ago, we manage the capital of our operating units based on clear local target and buffer levels as shown in the graphs. S&P excess capital in the Americas decreased by EUR 100 million as the impact of the midyear dividend paid to the holding was offset by earnings in the quarter and the benefit of higher interest rates. The IGD ratio in the Netherlands, excluding the bank and the benefit of the ultimate forward rate increased to 235%. And including the bank and the UFR, the ratio was 270%. This was driven by earnings and the benefit of yield curve changes. We used the ECB AAA curve to discount liabilities for Solvency purposes at the end of the second quarter. And as you know, as of mid-July, France is no longer included in this curve. The industry is currently working with the DNB to clarify what the right methodology should be going forward. The impact of the downgrade of France is approximately 35 percentage points on a regulatory Solvency ratio of 270%, which includes the bank in the UFR. We are comfortable that the capital position of our Dutch business will remain above our self-imposed target level. In the U.K., the Pillar 1 ratio increased to 170%, including the capital support from the parent, as the negative impact of downgrades and impairments was offset by the benefit of higher interest rates. Excess capital in the holding increased to EUR 1.9 billion as you can see on Slide 14. Dividends from our business units and proceeds from the exit of our joint venture with Unnim more than compensated for the cash used for the preferred share transaction, dividends to our shareholders, the investment in our new joint venture with Banco Santander, as well as funding and operating expenses. Financial leverage improved to 30.5%, following the redemption of a bond that matured during the quarter. Slide 15. Our strong capital position and operating free cash flows enable us to increase the interim dividend to EUR 0.11 per share, a clear sign of our confidence. We will continue to allow investors to choose between receiving the dividend in cash or stock, and as I indicated in June, we will neutralize the interim stock dividend. Back to Alex to wrap it up.